Dividend Payout Ratio: 72% of AFFO per share for Q1 2025. Agree Realty Corp (NYSE:ADC) invested over $375 million across its three external growth platforms, marking the largest quarter of ...

ADCs in Preclinical Development for the Treatment of B-cell Malignancies With the evolving clinical data demonstrating the feasibility of the ADC platform in hematologic malignancies, the ...

"MHB088C has demonstrated robust efficacy with great safety profiles, with no major hematological toxicity or ILD, positioning the program as a best-in-class B7-H3 ADC," Cao added. "With Qilu's ...

The ODT-ADS-7B64G-3 is an ultra-high-bandwidth time-interleaved ADC designed in a 3nm CMOS process. This 7-bit, 64GSPS ADC supports ac-coupled input signals up to Nyquist and features a full-scale ...

The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...

Superb internalization profile paired with proprietary linker technology underscore strong efficacy and optimal stability data; first-in-class ADC program currently in IND-enabling studies ...

French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).

The goal of the paper is to demonstrate that both the features can be achieved by a time-interleaved ADC architecture exploiting Successive Approximation (SA) algorithm. A 6-bit time-interleaved ...

The game's newest champion, who will likely take on an ADC role, was teased in the Season 2 Cinematic, Here Tomorrow, the Spirit Blossom Beyond cinematic. Various champions have appeared in the ...

AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...

The partnership unites OmniAb’s transgenic antibody discovery solutions with Veraxa’s ADC linker technology and conjugation expertise to propel next-generation therapeutic discovery. Veraxa will ...

The company has established one of the world's leading proprietary ADC platforms, OptiDC™, and has 1 ADC project approved for marketing, 1 ADC project in NDA stage, and multiple ADC or novel ADC ...